Study to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension
Clinical trial NCT05562362 · COMPLETED
Trial details
- NCT number
- NCT05562362
- Sponsor
- Travere Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-18
- Primary completion
- 2020-11-12
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.